Save your place

Sign in to WhoBought

Please try again later.

Viridian Therapeutics, Inc. (VRDN) institutional ownership

Latest close $19.26 Jul 23, 2026
Market cap$1.4B 52-week range SectorHealthcare
Funds holding · Q1 2026
236
reported VRDN position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
121 buyers · 115 sellers

Viridian Therapeutics, Inc. (VRDN) price and institutional activity

Dates

Q1 2026

$0 bought by 121 investors
Bellevue Group AGBalyasny Asset Management L.P. +119 more
$0 sold by 115 investors
Perceptive Advisors LLCDeep Track Capital, LP +113 more
Bought Sold Totals per quarter; hover a bar for the names.

Viridian Therapeutics, Inc. (VRDN) institutional activity · 236

Investor Type Est. change Change Δ Own Date
Bellevue Group AG · Added
Change +2.4M Date Q1 2026
Bellevue Group AG Added· Q1 2026 +2.4M Q1 2026
Perceptive Advisors LLC · Reduced
Change −1.9M Date Q1 2026
Perceptive Advisors LLC Reduced· Q1 2026 −1.9M Q1 2026
Balyasny Asset Management L.P. · Added
Change +1.8M Date Q1 2026
Balyasny Asset Management L.P. Added· Q1 2026 +1.8M Q1 2026
Paradigm Biocapital Advisors LP · Added
Change +1.7M Date Q1 2026
Paradigm Biocapital Advisors LP Added· Q1 2026 +1.7M Q1 2026
Citadel Advisors LLC Added· Q1 2026 +1.6M +241.1% Q1 2026
BlackRock · Added
Change +1.4M Date Q1 2026
BlackRock Added· Q1 2026 +1.4M Q1 2026
State Street · Added
Change +1.2M Date Q1 2026
State Street Added· Q1 2026 +1.2M Q1 2026
Deep Track Capital, LP · Reduced
Change −1.1M Date Q1 2026
Deep Track Capital, LP Reduced· Q1 2026 −1.1M Q1 2026
Jennison Associates LLC · Reduced
Change −1.1M Date Q1 2026
Jennison Associates LLC Reduced· Q1 2026 −1.1M Q1 2026
Wellington Management Group LLP · Added
Change +1.1M Δ Own +56.2% Date Q1 2026
Wellington Management Group LLP Added· Q1 2026 +1.1M +56.2% Q1 2026
Marshall Wace, LLP · Reduced
Change −1.1M Date Q1 2026
Marshall Wace, LLP Reduced· Q1 2026 −1.1M Q1 2026
Eversept Partners, LP · Reduced
Change −1.1M Date Q1 2026
Eversept Partners, LP Reduced· Q1 2026 −1.1M Q1 2026
FMR LLC · Added
Change +995K Δ Own +6.9% Date Q1 2026
FMR LLC Added· Q1 2026 +995K +6.9% Q1 2026
Vanguard · Added
Change +883K Date Q1 2026
Vanguard Added· Q1 2026 +883K Q1 2026
Kynam Capital Management, LP · Added
Change +871K Date Q1 2026
Kynam Capital Management, LP Added· Q1 2026 +871K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 236

Famous investor activity in Viridian Therapeutics, Inc. (VRDN)

Viridian Therapeutics, Inc. (VRDN) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Cain Christopher W. · Director Grant (A) 32K
Owned 32K Trade date Jul 1, 2026 Filed date Jul 2, 2026
Cain Christopher W. Director Grant (A) 32K 32K Jul 1, 2026 Jul 2, 2026
Ajer Jeffrey Robert · Director Grant (A) 32K
Owned 32K Trade date Jul 1, 2026 Filed date Jul 2, 2026
Ajer Jeffrey Robert Director Grant (A) 32K 32K Jul 1, 2026 Jul 2, 2026
Moses Jennifer K. · Director Grant (A) 32K
Owned 32K Trade date Jul 1, 2026 Filed date Jul 2, 2026
Moses Jennifer K. Director Grant (A) 32K 32K Jul 1, 2026 Jul 2, 2026
Gheuens Sarah · Director Grant (A) 32K
Owned 32K Trade date Jul 1, 2026 Filed date Jul 2, 2026
Gheuens Sarah Director Grant (A) 32K 32K Jul 1, 2026 Jul 2, 2026
Kiselak Tomas · Director Grant (A) 32K
Owned 32K Trade date Jul 1, 2026 Filed date Jul 2, 2026
Kiselak Tomas Director Grant (A) 32K 32K Jul 1, 2026 Jul 2, 2026
Morris Arlene · Director Grant (A) 32K
Owned 32K Trade date Jul 1, 2026 Filed date Jul 2, 2026
Morris Arlene Director Grant (A) 32K 32K Jul 1, 2026 Jul 2, 2026
Fairmount Funds Management LLC · Director Buy +$20M
Price $17.00 Qty +1.2M Owned 5.1M Trade date May 11, 2026 Filed date May 13, 2026
Fairmount Funds Management LLC Director Buy $17.00 +1.2M +$20M 5.1M May 11, 2026 May 13, 2026
Tousignant Jennifer · Officer 2 operations 0
Owned 16K Trade date Mar 3, 2026 Filed date Mar 4, 2026
Tousignant Jennifer Officer 2 operations 0 16K Mar 3, 2026 Mar 4, 2026
Tousignant Jennifer · Officer Tax withholding or exercise payment (F) -$51K
Price $29.32 Qty -2K Owned 3K Trade date Mar 3, 2026 Filed date Mar 4, 2026
Tousignant Jennifer Officer Tax withholding or exercise payment (F) $29.32 -2K -$51K 3K Mar 3, 2026 Mar 4, 2026
Harmon Seth · Officer 2 operations 0
Owned 19K Trade date Mar 3, 2026 Filed date Mar 4, 2026
Harmon Seth Officer 2 operations 0 19K Mar 3, 2026 Mar 4, 2026
Harmon Seth · Officer Tax withholding or exercise payment (F) -$61K
Price $29.32 Qty -2K Owned 8K Trade date Mar 3, 2026 Filed date Mar 4, 2026
Harmon Seth Officer Tax withholding or exercise payment (F) $29.32 -2K -$61K 8K Mar 3, 2026 Mar 4, 2026
Beetham Thomas W. · Officer 2 operations 0
Owned 28K Trade date Mar 3, 2026 Filed date Mar 4, 2026
Beetham Thomas W. Officer 2 operations 0 28K Mar 3, 2026 Mar 4, 2026
Beetham Thomas W. · Officer Tax withholding or exercise payment (F) -$92K
Price $29.32 Qty -3K Owned 13K Trade date Mar 3, 2026 Filed date Mar 4, 2026
Beetham Thomas W. Officer Tax withholding or exercise payment (F) $29.32 -3K -$92K 13K Mar 3, 2026 Mar 4, 2026
Mahoney Stephen F. · Officer 2 operations 0
Owned 55K Trade date Mar 3, 2026 Filed date Mar 4, 2026
Mahoney Stephen F. Officer 2 operations 0 55K Mar 3, 2026 Mar 4, 2026
Mahoney Stephen F. · Officer Tax withholding or exercise payment (F) -$224K
Price $29.32 Qty -8K Owned 33K Trade date Mar 3, 2026 Filed date Mar 4, 2026
Mahoney Stephen F. Officer Tax withholding or exercise payment (F) $29.32 -8K -$224K 33K Mar 3, 2026 Mar 4, 2026
15 of 22
15 of 22 Sign in to continue to older insider transactions.

Viridian Therapeutics, Inc. (VRDN) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Fairmount Funds Management LLC 15.6M
% of shares outstanding 17.9% Filing date Sep 17, 2024
Fairmount Funds Management LLC 15.6M 17.9% Sep 17, 2024
FMR LLC 7.6M
% of shares outstanding 14.5% Filing date Jan 10, 2024
FMR LLC 7.6M 14.5% Jan 10, 2024
Bellevue Group AG 6.7M
% of shares outstanding 6.6% Filing date May 15, 2026
Bellevue Group AG 6.7M 6.6% May 15, 2026
BlackRock Inc. 3.4M
% of shares outstanding 6.5% Filing date Jan 29, 2024
BlackRock Inc. 3.4M 6.5% Jan 29, 2024
Vanguard Group Inc 3.0M
% of shares outstanding 5.7% Filing date Feb 13, 2024
Vanguard Group Inc 3.0M 5.7% Feb 13, 2024
Venrock Healthcare Capital Partners Iii, L.P. 3.6M
% of shares outstanding 5.5% Filing date Nov 14, 2024
Venrock Healthcare Capital Partners Iii, L.P. 3.6M 5.5% Nov 14, 2024
Deep Track Capital, LP 5.4M
% of shares outstanding 5.3% Filing date May 8, 2026
Deep Track Capital, LP 5.4M 5.3% May 8, 2026
Paradigm Biocapital Advisors LP 5.6M
% of shares outstanding 5.1% Filing date Jun 26, 2026
Paradigm Biocapital Advisors LP 5.6M 5.1% Jun 26, 2026
8 of 17

Viridian Therapeutics, Inc. (VRDN) ownership FAQ

Who owns VRDN?

236 reporting institutions disclosed VRDN position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.